rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2009-11-25
|
pubmed:abstractText |
We evaluated discordance in expression measurements for estrogen receptor (ER), progesterone receptor (PR), and HER2 between primary and recurrent tumors in patients with recurrent breast cancer and its effect on prognosis.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1569-8041
|
pubmed:author |
pubmed-author:AlbarracinCC,
pubmed-author:BroglioKK,
pubmed-author:Gonzalez-AnguloA MAM,
pubmed-author:HortobagyiG NGN,
pubmed-author:IUSAA,
pubmed-author:KauS-WSW,
pubmed-author:KieselLL,
pubmed-author:LiedtkeCC,
pubmed-author:Meric-BernstamFF,
pubmed-author:MoulderSS,
pubmed-author:PusztaiLL,
pubmed-author:SymmansW FWF,
pubmed-author:TheriaultR LRL,
pubmed-author:WoodwardWW
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1953-8
|
pubmed:dateRevised |
2011-3-3
|
pubmed:meshHeading |
pubmed-meshheading:19596702-Adult,
pubmed-meshheading:19596702-Aged,
pubmed-meshheading:19596702-Breast Neoplasms,
pubmed-meshheading:19596702-Female,
pubmed-meshheading:19596702-Humans,
pubmed-meshheading:19596702-Immunohistochemistry,
pubmed-meshheading:19596702-In Situ Hybridization, Fluorescence,
pubmed-meshheading:19596702-Middle Aged,
pubmed-meshheading:19596702-Prognosis,
pubmed-meshheading:19596702-Receptor, erbB-2,
pubmed-meshheading:19596702-Receptors, Estrogen,
pubmed-meshheading:19596702-Receptors, Progesterone,
pubmed-meshheading:19596702-Recurrence
|
pubmed:year |
2009
|
pubmed:articleTitle |
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
|
pubmed:affiliation |
Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77039, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|